Global EditionASIA 中文雙語Fran?ais
    World
    Home / World / Asia-Pacific

    Japan gears up to begin clinical tests for vaccine

    By WANG XU | China Daily | Updated: 2020-06-19 13:44
    Share
    Share - WeChat
    A medical worker conducts a simulation for a walk-in style polymerase chain reaction (PCR) test for the coronavirus disease (COVID-19), at a makeshift facility in Yokosuka, south of Tokyo, Japan, April 23, 2020. [Photo/Agencies]

    Japan hopes to conduct clinical tests of a vaccine for the novel coronavirus by the end of June, local media reported, hoping it will be available to the general public as early as spring next year.

    According to Osaka Governor Hirofumi Yoshimura, the test will initially target 20 to 30 medical workers at Osaka City University Hospital, and is expected to expand to hundreds by October.

    "I think it will be the first clinical test (of a coronavirus vaccine) on humans in Japan," Yoshimura said.

    Starting from April, the prefectural and municipal governments of Osaka as well as AnGes Inc, a startup set up by an Osaka University professor, have been working on treatment drugs and vaccines for the coronavirus.

    By injecting a genetically engineered circular DNA into the body, the envisioned vaccine is expected to stimulate the immune system and make antibodies against the coronavirus.

    "Early results from tests in mice showed increased antibody production and had proven its safety," Yoshimura said, adding that it is possible to produce the DNA vaccine for 200,000 people by the end of this year.

    Meanwhile, Ryuichi Morishita, a professor of clinical gene therapy at Osaka University and founder of the AnGes, said the university will increase the number of people given the vaccine in stages while working to confirm whether antibodies can be produced.

    "We hope the vaccine will become available to the general public between spring and autumn next year," Morishita said.

    Promising candidate

    AnGes' candidate is one of Japan's best hopes for a novel coronavirus vaccine as development is further along than others being produced by firms such as Shionogi& Co and Daiichi Sankyo Co.

    Currently, around 125 vaccines are under development globally, including 10 in human testing, according to the World Health Organization.

    Among them, vaccines from China's CanSino Biologics Inc, US biotechnology company Moderna Inc and British pharmaceutical giant AstraZeneca Plc are already in clinical trials.

    Agencies via Xinhua contributed to this story.

    Most Viewed in 24 Hours
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    无码中文av有码中文a| 中文字幕国产第一页首页| 中文成人久久久久影院免费观看| 无码精品人妻一区二区三区漫画| 午夜不卡无码中文字幕影院| 精品无码一区二区三区爱欲九九| 日日麻批免费40分钟无码| 亚洲中文字幕无码不卡电影| 无码av免费一区二区三区试看| 亚洲中文字幕久久精品无码喷水 | 国产AV无码专区亚洲AV漫画 | 亚洲中文字幕久久精品无码APP| 国产日韩精品中文字无码| 极品粉嫩嫩模大尺度无码视频| 精品久久久久中文字幕日本 | 在线中文字幕播放| 亚洲一级Av无码毛片久久精品| 无码国产精品一区二区免费式芒果| 中文字幕精品无码久久久久久3D日动漫 | 天天看高清无码一区二区三区| 久久久久久国产精品免费无码| 亚洲av激情无码专区在线播放| 中文字幕在线看日本大片| 亚洲欧美中文字幕| yellow中文字幕久久网| 人妻无码中文久久久久专区| 中文字幕亚洲码在线| 亚洲日韩VA无码中文字幕| 精品久久久久久无码人妻热 | 中文字幕无码高清晰| 无码少妇一区二区浪潮av| 无码人妻少妇伦在线电影| 无码人妻精品一区二区蜜桃百度 | 亚洲中文字幕日本无线码| 亚洲Aⅴ无码一区二区二三区软件 亚洲?V无码乱码国产精品 | 久久中文字幕人妻熟av女| 中文人妻无码一区二区三区| 香蕉伊蕉伊中文视频在线| 最新版天堂资源中文网| 日韩欧美中文字幕一字不卡| 国产av无码专区亚洲av果冻传媒|